Andersen-Tawil syndrome screening: Difference between revisions
Line 15: | Line 15: | ||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for Andersen-Tawil syndrome. | |||
* There is insufficient evidence to recommend routine screening for Andersen-Tawil syndrome. | |||
* But when a patient with positive KCNJ2 mutation and have no symtoms in Andersen-Tawil syndrome yearly screening with the following should be considered | |||
** A 12-lead ECG | |||
** 24-hour Holter monitoring | |||
OR | OR |
Revision as of 20:59, 30 January 2020
Xyz Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Andersen-Tawil syndrome screening On the Web |
American Roentgen Ray Society Images of Andersen-Tawil syndrome screening |
Risk calculators and risk factors for Andersen-Tawil syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for Andersen-Tawil syndrome.
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
- There is insufficient evidence to recommend routine screening for Andersen-Tawil syndrome.
- But when a patient with positive KCNJ2 mutation and have no symtoms in Andersen-Tawil syndrome yearly screening with the following should be considered
- A 12-lead ECG
- 24-hour Holter monitoring
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]